Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Somatostatin receptors on… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Somatostatin receptors on neuroendocrine tumors--a way to intraoperative diagnosis and localization.

Artikel i vetenskaplig tidskrift
Författare Håkan Ahlman
Lars-Eric Tisell
Bo Wängberg
Ola Nilsson
M Fjälling
Eva Forssell-Aronsson
Publicerad i The Yale journal of biology and medicine
Volym 67
Nummer/häfte 3-4
Sidor 215-21
ISSN 0044-0086
Publiceringsår 1994
Publicerad vid Institutionen för särskilda specialiteter, Avdelningen för radiofysik
Institutionen för de kirurgiska disciplinerna, Avdelningen för kirurgi
Sidor 215-21
Språk en
Länkar www.ncbi.nlm.nih.gov/entrez/query.f...
Ämnesord Carcinoid Tumor, diagnosis, surgery, Carcinoma, Neuroendocrine, diagnosis, surgery, Evaluation Studies as Topic, Humans, Intestinal Neoplasms, diagnosis, surgery, Monitoring, Intraoperative, methods, Octreotide, analogs & derivatives, diagnostic use, Pentetic Acid, analogs & derivatives, diagnostic use, Radionuclide Imaging, methods, Receptors, Somatostatin, isolation & purification, Thyroid Neoplasms, diagnosis, surgery
Ämneskategorier Gastroenterologi, Cancer och onkologi, Kirurgi

Sammanfattning

Intraoperative radionuclide detection using 111In-DTPA-D-Phe1-octreotide was evaluated in five patients with midgut carcinoids and in three patients with recurrent medullary thyroid carcinoma. Three different time intervals (24, 48 and 120 hr) from injection of the radiopharmaceutical to surgery were used. At surgery, suspect tumors were measured by probe in situ and ex vivo after excision. All tissue specimens and blood samples withdrawn during surgery were measured for 111In activity, and tissue/blood activity concentration ratios were calculated. In situ measurements were valuable especially in neck surgery, where the probe was helpful not only in localization of tumors but also in the control of tumor clearance. Ex vivo measurements were helpful in diagnosing tumor tissue. All five patients with midgut carcinoids were somatostatin receptor-positive, while only three out of seven patients with medullary thyroid carcinoma were receptor-positive. The tissue/blood activity concentration ratios and probe measurement ratios were in general higher in patients with midgut carcinoid than in patients with medullary thyroid carcinoma. Of particular interest were the high tissue/blood concentration ratios in all receptor-positive patients at all time intervals studied. This fact suggests a potential role for radiolabelled octreotide in radiotherapy of these tumor types.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?